Q32 Bio

Developer of drugs for treating autoimmune disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups34 employees language q32bio.com

Registered entities

Innovation

7 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 301 times.

YearFilings
20201
20212
20221
20231
20242
20256
20262

Social engagement

Social engagement: 5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Atlas Venture, Orbimed, Acorn Bioventures; 1 has since exited.

Investor typeCountShare
Venture capital873%
Other / undisclosed327%

Recent activity

23 Jun 2026
Event
Annual National Alopecia Areata Foundation Conference
8 Apr 2026
Event
25th Annual Needham & Company Virtual Healthcare Conference
26 Mar 2026
Event
MassBio State of Possible Conference
Coming soon